Removal of anti-A/B antibodies with plasmapheresis in ABO-incompatible kidney transplantation. 2000

H Shimmura, and K Tanabe, and N Ishikawa, and T Tokumoto, and S Fuchinoue, and K Takahashi, and H Toma, and T Agishi
Department of Urology, Kidney Center, Tokyo Women's Medical University, Japan. hmax.shimmura@nifty.ne.jp

Because of a shortage of cadaver donors in Japan, ABO-incompatible living kidney transplantation has been carried out. Sixty-seven ABO-incompatible living kidney transplantations (LKT) were performed between January 1989 and December 1995 at our institution. In our previous report on the long-term results of ABO-incompatible LKT, graft survival of ABO-incompatible LKT up to 3 years was significantly lower than that of ABO-compatible LKT, but no significant difference was seen from 4 to 8 years. We removed anti-A/B antibodies by immunoadsorption and/or double filtration plasmapheresis before kidney transplantation. There was a significant difference between the anti-A/B antibody titers before and after plasmapheresis. The anti-A/B antibody titers also were well suppressed over the long term after transplantation.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007518 Isoantibodies Antibodies from an individual that react with ISOANTIGENS of another individual of the same species. Alloantibodies
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010956 Plasmapheresis Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use. Double Filtration Plasmapheresis,Therapeutic Immunoadsorption,Therapeutic Plasma Adsorption,Therapeutic Plasmapheresis,Adsorption, Therapeutic Plasma,Adsorptions, Therapeutic Plasma,Double Filtration Plasmaphereses,Filtration Plasmapheresis, Double,Immunoadsorption, Therapeutic,Plasma Adsorption, Therapeutic,Plasmaphereses,Plasmapheresis, Double Filtration,Plasmapheresis, Therapeutic,Therapeutic Immunoadsorptions,Therapeutic Plasma Adsorptions,Therapeutic Plasmaphereses
D001787 Blood Group Incompatibility An antigenic mismatch between donor and recipient blood. Antibodies present in the recipient's serum may be directed against antigens in the donor product. Such a mismatch may result in a transfusion reaction in which, for example, donor blood is hemolyzed. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984). ABO Compatibility,ABO Incompatibility,Blood Group ABO Incompatibility,Blood Type Incompatibility,Rh Compatibility,Rh Incompatibility,ABO Compatibilities,ABO Incompatibilities,Blood Group Incompatibilities,Blood Type Incompatibilities,Compatibility, ABO,Compatibility, Rh,Incompatibilities, Blood Group,Incompatibility, ABO,Incompatibility, Blood Group,Incompatibility, Blood Type,Incompatibility, Rh,Rh Compatibilities,Rh Incompatibilities
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

H Shimmura, and K Tanabe, and N Ishikawa, and T Tokumoto, and S Fuchinoue, and K Takahashi, and H Toma, and T Agishi
September 1996, Transfusion science,
H Shimmura, and K Tanabe, and N Ishikawa, and T Tokumoto, and S Fuchinoue, and K Takahashi, and H Toma, and T Agishi
March 2006, Xenotransplantation,
H Shimmura, and K Tanabe, and N Ishikawa, and T Tokumoto, and S Fuchinoue, and K Takahashi, and H Toma, and T Agishi
May 1987, Schweizerische medizinische Wochenschrift,
H Shimmura, and K Tanabe, and N Ishikawa, and T Tokumoto, and S Fuchinoue, and K Takahashi, and H Toma, and T Agishi
November 1986, Blut,
H Shimmura, and K Tanabe, and N Ishikawa, and T Tokumoto, and S Fuchinoue, and K Takahashi, and H Toma, and T Agishi
April 2023, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis,
H Shimmura, and K Tanabe, and N Ishikawa, and T Tokumoto, and S Fuchinoue, and K Takahashi, and H Toma, and T Agishi
March 2022, Transplantation proceedings,
H Shimmura, and K Tanabe, and N Ishikawa, and T Tokumoto, and S Fuchinoue, and K Takahashi, and H Toma, and T Agishi
December 2009, The Korean journal of laboratory medicine,
H Shimmura, and K Tanabe, and N Ishikawa, and T Tokumoto, and S Fuchinoue, and K Takahashi, and H Toma, and T Agishi
January 2020, Pediatric nephrology (Berlin, Germany),
H Shimmura, and K Tanabe, and N Ishikawa, and T Tokumoto, and S Fuchinoue, and K Takahashi, and H Toma, and T Agishi
April 1992, Transplantation proceedings,
H Shimmura, and K Tanabe, and N Ishikawa, and T Tokumoto, and S Fuchinoue, and K Takahashi, and H Toma, and T Agishi
April 1998, Clinical transplantation,
Copied contents to your clipboard!